Cannabis and Hemp Sector Ideas

[TheMonolith]

Please find me a better chart than NMUS in the cannabis sector or any sector for that matter. That way I can make 400%!

-The University of Mississippi (UM) is the only entity in the US
authorized by NIDA and the DEA to cultivate cannabis on behalf of
the federal government for 50 years

-NEMUS has exclusive, perpetual, worldwide exclusivity for all
compounds and targets we are working on with UM for key fields of
delivery

-Patents have been issued for the proprietary prodrug of THC in the
USA (2014), Japan (2015), Australia (2016); EU (2017); UK (2017)
Canada (2017), and Hong Kong (2017)

-Nemus and the University are currently engaged in the development
of third-generation hybrid synthetic cannabinoid molecules with the
goal of becoming the leading developer of second- and thirdgeneration
compounds in the field of cannabinoid-related medicines




NB2111 exhibits comparable pain control compared to morphine in animal CIPN study

NB2111 demonstrated anti-addiction qualities

NB2111 is a CBD-like molecule tested in a murine model of tactile allodynia replicating the neuropathy associated with exposure to the chemotherapeutic agent of cisplatin (used in lung, breast and colon cancers)

• NB2111 resulted in significant analgesia in this model with analgesic coverage commensurate with that seen using the highest dose of morphine exposure

• Data demonstrate an efficacious dose of NB2111 blocks oxycodone (OXY)
reward when combined with sub-analgesic and analgesic dosages of OXY

• Studies to be planned examining both analgesia potential and anti-abuse
advantage when dosing NB2111

• Dual profile of analgesia and abuse attenuation, NB2111 could be a potentialprimary or adjunctive therapy in managing CINP as well as other types of pain syndromes